Nexafed is a formulation of pseudoephedrine developed by Acura Pharmaceuticals used to deter the use of the pseudoephedrine contained in the product for illicit methamphetamine synthesis.[1] Nexafed uses a polymer matrix that forms a thick gel when hydrated, preventing the extraction of pseudoephedrine.[2] Nexafed is the only meth-resistant formulation of pseudoephedrine that shows therapeutic equivalence to Sudafed.[3]
It is sold at various pharmacies in the US, including Fruth Pharmacy[4][5] and Kroger, particularly in communities where illicit methamphetamine production is an issue.[citation needed]
References
edit- ^ "In fight against crystal meth, a focus on chemistry". cbsnews.com. 2 August 2013. Retrieved 18 July 2016.
- ^ Ricker, Nok-Noi (2016-07-02). "Pharmacies in northern Maine halt sales of certain decongestants to thwart meth labs". Bangor Daily News. Retrieved 2021-11-07.
- ^ Brzeczko, Albert W.; Leech, Ronald; Stark, Jeffrey G. (2013). "The advent of a new pseudoephedrine product to combat methamphetamine abuse". The American Journal of Drug and Alcohol Abuse. 39 (5): 284–290. doi:10.3109/00952990.2013.821476. ISSN 0095-2990. PMC 3793278. PMID 23968171.
- ^ "Fruth Pharmacy recognized for fighting meth production". drugstorenews.com. Retrieved 18 July 2016.
- ^ Anna Baxter, The Associated Press. "Fruth Pharmacy to Stop Selling Certain Medications to Fight Meth Abuse". wsaz.com. Retrieved 18 July 2016.
External links
edit
 | This pharmacology-related article is a stub. You can help Wikipedia by expanding it. |